Thursday, December 08, 2022
2:30 PM-3:30 PM ET
Elizabeth P. Clayborne, MD, MA
Adjunct Assistant Professor
Emergency Medicine Physician
Prince George's Hospital Center
University of Maryland School of Medicine
Baltimore, Maryland
Lewis W. Teperman, MD, FACS
Vice Chair, Organ Transplant Surgery
Director, Organ Transplantation
Professor of Surgery and Medicine
Zucker School of Medicine at Hofstra
Northwell Health
New York, New York
Target Audience
The educational design of this activity addresses the needs of infectious disease specialists, internal medicine physicians, transplant specialists, oncologist, pharmacists, and other clinicians involved in managing patients who are at heightened risk for poor COVID-19 outcomes.
Educational Objectives
After completing this activity, the participant should be better able to:
- Discuss recent trial data and current regulatory status for anti-SARS-CoV-2 monoclonal antibodies
- Identify candidates for pre-exposure prophylaxis or treatment with anti-SARS-CoV-2 monoclonal antibodies, including immunocompromised patients
- Create proactive plans with patients, other clinicians, and healthcare systems to ensure prompt and equitable use of anti-SARS-CoV-2 monoclonal antibodies for pre-exposure prophylaxis or treatment
Program Description
The presence of multiple new COVID-19 variants and subvariants has rapidly shifted strategies for treatment and prevention. Clinicians struggle to remain up to date with a rapidly changing field that has remained a public health concern, including guidelines, Emergency Use Authorization status, and challenges with logistical implementation. Regional faculty will present data on and discuss current evidence and regulatory status for anti-SARS-CoV-2 monoclonal antibodies for treatment and prevention and available antivirals for treatment, updates to National Institutes of Health guidelines on patient identification, and strategies to reduce health care disparities. Each regional webinar will include an extensive Q&A session for audience participation.
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Integritas Communications. Global is accredited by the ACCME to provide continuing medical education for physicians.
*This CME/CE activity complies with all requirements of the federal Physician Payment Sunshine Act. If a reportable event is associated with this activity, the accredited provider managing the program will provide the appropriate physician data to the Open Payments database.
Physician Credit Designation
Global designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurse Practitioner Continuing Education
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of Global and Integritas Communications. Global is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 110121. This activity is approved for 1.0 contact hour(s) (which includes 0.1 hour(s) of pharmacology).
Global Contact Information
For information about the approval of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.
Fee Information& Refund/Cancellation Policy
There is no fee for this educational activity.
Disclosures of Conflicts of Interest
Global adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.
This activity is jointly provided by Global Education Group and Integritas Communications.
This activity is supported by independent educational grants from AstraZeneca.
Register Now
08
2024
BRIDGE HCV
Building Bridges To Reach People Who Inject Drugs With The Goal To Eliminate HCV
Time: | 12:00 PM-1:00 PM CT |
Venue: | Health Service Inc. - In-Person Event |
Location: | Montgomery, AL |
Faculty: | William S. Bradford, MD |
11
2024
BRIDGE HCV
Building Bridges To Reach People Who Inject Drugs With The Goal To Eliminate HCV
Time: | 12:30 PM-1:30 PM CT |
Venue: | Cahaba Medical Care - In-Person Event |
Location: | Birmingham, AL |
Faculty: | Audrey R. Lloyd, MD |
17
2024
BRIDGE HCV
Building Bridges To Reach People Who Inject Drugs With The Goal To Eliminate HCV
Time: | 12:00 PM-1:00 PM CT |
Venue: | Mobile County Health Dept. - In-Person Event |
Location: | Mobile, AL |
Faculty: | Audrey R. Lloyd, MD |
19
2024
BRIDGE HCV
Building Bridges To Reach People Who Inject Drugs With The Goal To Eliminate HCV
Time: | 12:00 PM-1:00 PM CT |
Venue: | Mobile County Health Dept. - In-Person Event |
Location: | Mobile, AL |
Faculty: | William S. Bradford, MD |
22
2024
BRIDGE HCV
Building Bridges To Reach People Who Inject Drugs With The Goal To Eliminate HCV
Time: | 12:00 PM-1:00 PM CT |
Venue: | Health Service Inc. - In-Person Event |
Location: | Montgomery, AL |
Faculty: | Audrey R. Lloyd, MD |
24
2024
BRIDGE HCV
Building Bridges To Reach People Who Inject Drugs With The Goal To Eliminate HCV
Time: | 12:30 PM-1:30 PM CT |
Venue: | Cahaba Medical Care - In-Person Event |
Location: | Birmingham, AL |
Faculty: | Ellen F. Eaton, MD, MSPH, FIDSA |